ENO1 Antibody [N16N23]

Katalog-Nr. F2363

Drucken

Biologische Beschreibung

Spezifität

ENO1 Antibody [N16N23] erkennt endogene Spiegel des gesamten ENO1-Proteins.
Hintergrund

Enolase 1 (ENO1) ist ein multifunktionales Enzym, das eine entscheidende Rolle im glykolytischen Stoffwechselweg spielt und die Umwandlung von 2-Phosphoglycerat zu Phosphoenolpyruvat erleichtert, ein wichtiger Schritt in der ATP-Produktion. Strukturell nimmt ENO1 eine geschlossene Konformation mit L1-, L2- und L3-Schleifen ein, die das aktive Zentrum umgeben, welches Magnesiumionen enthält, die für seine enzymatische Funktion unerlässlich sind. ENO1 bindet auch Plasminogen und wandelt es in Plasmin um, das matrixabbauende Enzyme aktiviert und eine Rolle bei Gewebeumbau, Zellinvasion und Metastasierung spielt. ENO1 fungiert als nukleäres DNA-bindendes Protein, das die Gentranskription reguliert und als Autoantigen bei Autoimmunerkrankungen wirkt. Die Oberflächenmerkmale von ENO1 weisen positiv geladene Reste auf, die zu seiner DNA-Bindungsfähigkeit und Plasminogenbindung beitragen. Es ist an verschiedenen zellulären Funktionen wie Zellwachstum, Differenzierung, Migration, Apoptose und Zytoskelettregulation beteiligt, die für die Gewebeentwicklung, Wundheilung und Immunantworten entscheidend sind. ENO1 ist häufig bei Krebserkrankungen wie Brust-, Lungen- und Leberkrebs überexprimiert und fördert die Tumorentwicklung und Metastasierung. Es spielt auch eine Rolle bei Autoimmunerkrankungen, wobei Anti-ENO1-Antikörper bei Erkrankungen wie rheumatoider Arthritis und Lupus nachgewiesen wurden. Bei parasitären Infektionen ist ENO1 auf der Oberfläche von Plasmodium falciparum-Merozoiten vorhanden und beeinflusst die Immunerkennung und das Überleben des Parasiten. Zusätzlich trägt ENO1 zur Spermienmotilität und ATP-Produktion bei, die für die männliche Fruchtbarkeit unerlässlich sind, und ist an der Muskelentwicklung und -regeneration beteiligt.

Nutzungsinformationen

Anwendung WB, IP, IF, FCM Verdünnung
WB IP IF FCM
1:1000-1:10000 1:50 1:60 1:50
Reaktivität Human, Mouse, Rat
Quelle Rabbit Monoclonal Antibody MW 47 Kda
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Lagerung
(Ab dem Datum des Erhalts)		 -20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail)，and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
2. Adherent cell: Aspirate the culture medium and transfer the cells into an EP tube. Wash the cells with ice-cold PBS twice. Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice.Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1225. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IF
Experimental Protocol:
 
Sample Preparation
1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
 
Fixation
1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
2. Wash the sample with PBS for 3 times, 3 minutes each time.
 
Blocking
Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
 
Immunofluorescence Staining (Day 1)
1. Remove the blocking solution and add the diluted primary antibody.
2. Incubate the sample in a humidified chamber at 4°C overnight.
 
Immunofluorescence Staining (Day 2)
1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
5. Wash with PBST for 3 times, 5 minutes each time.
 
Mounting
1. Mount the sample with an anti-fade mounting medium.
2. Allow the slide to dry at room temperature overnight in the dark.
3. Store the slide in a slide storage box at 4°C, protected from light.

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/18560153/
  • https://pubmed.ncbi.nlm.nih.gov/29767008/

Anwendungsdaten

WB

Validiert von Selleck

  • F2363-wb
    Lane 1: MCF7
    Lane 2: Jurkat
    Lane 3: A431
    Lane 4: HeLa
    Lane 5: C2C12
    Lane 6: NIH/3T3

IF

Validiert von Selleck

  • F2363-IF
    Immunofluorescent analysis of MCF-7 cells using F2363 (green, 1:50), Hoechst (blue) and tubulin (Red).